My Portfolio May21

Summary For May 2021

Portfolio @ End of May21

Due to the slump in SCIB share price, my portfolio suffers its heaviest loss in one month at -19% since losing 21.7% in Mac20. 

SCIB was my major holding and made up ~40% of my portfolio. It has contributed massively to my portfolio gain this year but now I have to vomit out those gain.

The big news in the stock market in May should be none other than Serba Dinamik's audit issue.

Serbadk first announced its intention to appoint an independent firm to commence a special independent review on its accounting matters raised by external auditor KPMG on 25th May 2021.

It's then followed by a public holiday, 2 days of trading suspension and 2 days of weekend. 

When trading resumed on the 31 May, its share price straight away limited down.

My Portfolio Apr21

Summary For April 2021

Stock Portfolio @ End of Apr21

Time flies and we are almost half way through the "recovery year" of 2021.

In the final quarter of year 2020, I was optimistic about recovery from the pandemic in 2021. I visualized that in the middle of 2021, we would lead an almost "normal" life.

However, the reality is far from that. Daily new Covid-19 cases soar pass 3000 now, from 1000+ cases in March.

Perhaps due to the start of vaccination program since February and significant drop in new cases in March, people are getting more slack in adhering to the SOP.

Anyway, the pandemic will be over one day. Year 2021 might be a transition year while 2022 will be a real recovery year in term of our daily activities.

Stock portfolio performance wise, it's a "not bad" month for me in April, as overall portfolio gains 4.56% in a month.

My Portfolio Mac21

Summary for March 2021

Portfolio @ End of Mac21

In general, March 2021 is not a good month in stock market. My portfolio lost 7.1%, mainly due to the decline of my major holdings SCIB & Jaks.

Taking some profit from SCIB earlier in the month helps to reduce the percentage of loss.

I still hold quite a lot of SCIB shares. I believe the company can continue to grow in 2021 and hope that it can achieve its RM2bil market cap target by the end of this year.

Jaks just released a bad quarter result with a shocking RM103mil loss after tax and minority interest in its FY20Q4. Its loss before tax for the quarter is RM183.5mil.

However, there are reversal of disposal gain (RM85.3mil), impairment loss of goodwill (RM52mil) & receivables (RM23.6mil), share grant plan expenses (RM17.1mil) and loss on disposal of investment properties (RM5mil) in this quarter alone.

After deducting all those bigger items above, its actual loss before tax is just RM0.5mil in the quarter which is not too bad.

Tecfast: A Fishy Big Contract?

Recently there are quite a few of small companies getting big contracts worth hundreds of millions to billions of ringgit.

What I know are ARB, Ageson, Anzo, Bioalpha, Vivocom, Kanger, Techfast etc.

Are they for real? While it certainly smell a bit fishy but I'm not going to comment about them since I don't study them in detail.

Readers can check the share price charts and the latest financial results of those companies to decide whether to believe in those companies or not. 

On 15th Mac 2021, Techfast announced that it has entered into a marine fuel oil supply agreement with Wise Marine Pte Ltd.

The value of this 3-year contract is estimated to be a whopping RM2.22 billion, and Tecfast is an ACE-listed company with a market cap of only RM100mil.

Nevertheless, Tecfast is still a profit-making company with zero borrowings.